CryoCath CE-marks AF (Atrial Fibrillation)Arctic Front System
This article was originally published in Clinica
Executive Summary
CryoCath Technologies has CE-marked for sale in Europe its Arctic Front catheter designed for the treatment of atrial fibrillation (AF), a condition characterised by rapid quivering of the two top chambers (atrium) in the heart. The company has also CE-marked its next-generation console for use with Arctic Front and its FlexCath deflectable sheath.